Objective: Cognitive impairment in multiple sclerosis (MS) has a complex relationship with disease progression and neurodegeneration. The aim of this study was to shed light on the importance of early detection of cognitive impairment in MS patients. Methods: The study comprised two groups of definite MS patients, relapsing remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS), each with 25 patients. Physical disability was assessed using the Expanded Disability Status Scale (EDSS), while the risk of secondary progression was assessed using the Bayesian Risk Estimate for Multiple Sclerosis (BREMS). Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and Controlled Oral Word Association Test (COWAT). Assessment of neurodegeneration was done using optical coherence tomography (OCT) via quantification of retinal nerve fiber layer (RNFL). Results: MS patients with higher RNFL thickness demonstrated a larger learning effect size than patients who had lower values in RNFL thickness regardless of MS type. RRMS patients showed significant improvement in delayed recall after giving cues than SPMS. The symbol digit modalities test was the only neuropsychological test that showed a significant negative correlation with EDSS (P= 0.009). There was a statistically significant negative correlation between BREMS scores and performance in all neuropsychological tests. Conclusion: Inclusion of neurocognitive evaluation in the periodic assessment of MS patients is mandatory to detect patients at increased risk of secondary progression. The thickness of RNFL is suggested as a method to estimate the expected benefit of cognitive rehabilitation, regardless of MS type.
机构:
Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, GermanyUniv Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, Germany
Heesen, C.
Schulz, K. H.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, D-20246 Hamburg, Germany
Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary Surg, D-20246 Hamburg, GermanyUniv Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, Germany
Schulz, K. H.
Fiehler, J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Med Ctr Hamburg Eppendorf, Dept Neuroradiol, D-20246 Hamburg, GermanyUniv Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, Germany
Fiehler, J.
Von der Mark, U.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, GermanyUniv Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, Germany
Von der Mark, U.
Otte, C.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Med Ctr Hamburg Eppendorf, Dept Psychiat, D-20246 Hamburg, GermanyUniv Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, Germany
Otte, C.
Jung, R.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, D-20246 Hamburg, GermanyUniv Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, Germany
Jung, R.
Poettgen, J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, GermanyUniv Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, Germany
Poettgen, J.
Krieger, T.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Med Ctr Hamburg Eppendorf, Dept Immunol, D-20246 Hamburg, GermanyUniv Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, Germany
Krieger, T.
Gold, S. M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, Dept Neurol, Sch Med, Multiple Sclerosis Program, Los Angeles, CA 90095 USAUniv Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, D-20246 Hamburg, Germany